UBX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Unity Biotechnology Inc (UBX).


$28.22M Market Cap.

As of 04/15/2024 5:00 PM ET (MRY) • Disclaimer

UBX Market Cap. (MRY)


UBX Shares Outstanding (MRY)


UBX Assets (MRY)


Total Assets

$65.69M

Total Liabilities

$37.29M

Total Investments

$24.29M

UBX Income (MRY)


Revenue

$0

Net Income

-$39.86M

Operating Expense

$44.67M

UBX Cash Flow (MRY)


CF Operations

-$37.09M

CF Investing

$60.49M

CF Financing

-$16.34M

UBX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

UBX Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$65,690,000 (-47.17%)

$124,350,000 (-0.29%)

$124,712,000 (-20.22%)

$156,319,000 (3.37%)

Assets Current

$46,605,000 (-51.72%)

$96,535,000 (6.66%)

$90,504,000 (-10.27%)

$100,866,000 (-22.10%)

Assets Non-Current

$19,085,000 (-31.39%)

$27,815,000 (-18.69%)

$34,208,000 (-38.31%)

$55,453,000 (155.14%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$28,398,000 (-57.52%)

$66,848,000 (12.22%)

$59,569,000 (-28.13%)

$82,880,000 (-31.34%)

Property Plant & Equipment Net

$18,063,000 (-32.77%)

$26,867,000 (-13.97%)

$31,228,000 (-13.58%)

$36,136,000 (117.22%)

Cash & Equivalents

$19,803,000 (55.49%)

$12,736,000 (-61.93%)

$33,455,000 (87.88%)

$17,807,000 (-54.25%)

Accumulated Other Comprehensive Income

-$24,000 (90.44%)

-$251,000 (-470.45%)

-$44,000 (-980.00%)

$5,000 (-94.44%)

Deferred Revenue

$0 (0%)

$0 (0%)

$216,000 (0%)

$0 (0%)

Total Investments

$24,294,000 (-70.71%)

$82,955,000 (42.88%)

$58,059,000 (-41.48%)

$99,209,000 (6.63%)

Investments Current

$23,398,000 (-71.49%)

$82,059,000 (48.74%)

$55,170,000 (-30.94%)

$79,892,000 (-11.25%)

Investments Non-Current

$896,000 (0.00%)

$896,000 (-68.99%)

$2,889,000 (-85.04%)

$19,317,000 (538.58%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$1,380,000 (-22.91%)

$1,790,000 (-9.82%)

$1,985,000 (-22.40%)

$2,558,000 (-50.67%)

Accumulated Retained Earnings (Deficit)

-$484,353,000 (-5.31%)

-$459,951,000 (-14.98%)

-$400,024,000 (-17.90%)

-$339,299,000 (-38.23%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$23,539,000 (-50.30%)

$47,358,000 (-9.83%)

$52,521,000 (-10.95%)

$58,976,000 (0%)

Debt Current

$0 (0%)

$9,476,000 (135.84%)

$4,018,000 (0%)

$0 (0%)

Debt Non-Current

$23,539,000 (-37.86%)

$37,882,000 (-21.90%)

$48,503,000 (-17.76%)

$58,976,000 (0%)

Total Liabilities

$37,292,000 (-35.15%)

$57,502,000 (-11.73%)

$65,143,000 (-11.30%)

$73,439,000 (140.67%)

Liabilities Current

$7,840,000 (-60.04%)

$19,620,000 (18.07%)

$16,617,000 (14.89%)

$14,463,000 (-15.99%)

Liabilities Non-Current

$29,452,000 (-22.25%)

$37,882,000 (-21.93%)

$48,526,000 (-17.72%)

$58,976,000 (343.50%)

UBX Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$0 (0%)

$236,000 (-95.07%)

$4,784,000 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$18,966,000 (-9.47%)

$20,949,000 (-9.14%)

$23,056,000 (-4.03%)

$24,025,000 (19.85%)

Research & Development Expense

$20,099,000 (-45.47%)

$36,859,000 (-4.00%)

$38,393,000 (-42.96%)

$67,309,000 (-5.14%)

Operating Expenses

$44,667,000 (-22.73%)

$57,808,000 (-5.93%)

$61,449,000 (-34.58%)

$93,930,000 (4.77%)

Interest Expense

$2,452,000 (-31.08%)

$3,558,000 (11.99%)

$3,177,000 (145.90%)

$1,292,000 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$39,860,000 (33.49%)

-$59,927,000 (1.31%)

-$60,725,000 (35.29%)

-$93,844,000 (-14.20%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$39,860,000 (33.49%)

-$59,927,000 (1.31%)

-$60,725,000 (35.29%)

-$93,844,000 (-14.20%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$39,860,000 (33.49%)

-$59,927,000 (1.31%)

-$60,725,000 (35.29%)

-$93,844,000 (-14.20%)

Weighted Average Shares

$14,773,612 (55.60%)

$9,494,421 (70.10%)

$5,581,587 (9.73%)

$5,086,489 (16.60%)

Weighted Average Shares Diluted

$14,773,612 (55.60%)

$9,494,421 (70.10%)

$5,581,587 (9.73%)

$5,086,489 (16.60%)

Earning Before Interest & Taxes (EBIT)

-$37,408,000 (33.64%)

-$56,369,000 (2.05%)

-$57,548,000 (37.82%)

-$92,552,000 (-12.63%)

Gross Profit

$0 (0%)

$236,000 (-95.07%)

$4,784,000 (0%)

$0 (0%)

Operating Income

-$44,667,000 (22.42%)

-$57,572,000 (-1.60%)

-$56,665,000 (39.67%)

-$93,930,000 (-4.77%)

UBX Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

$60,495,000 (346.47%)

-$24,545,000 (-162.43%)

$39,313,000 (854.86%)

-$5,208,000 (-107.66%)

Net Cash Flow from Financing

-$16,340,000 (-129.79%)

$54,855,000 (163.16%)

$20,845,000 (-67.37%)

$63,875,000 (132.80%)

Net Cash Flow from Operations

-$37,088,000 (27.32%)

-$51,029,000 (-13.25%)

-$45,060,000 (42.48%)

-$78,333,000 (-8.16%)

Net Cash Flow / Change in Cash & Cash Equivalents

$7,067,000 (134.11%)

-$20,719,000 (-237.23%)

$15,098,000 (176.77%)

-$19,666,000 (-185.62%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$60,391,000 (343.25%)

-$24,827,000 (-162.84%)

$39,508,000 (966.02%)

-$4,562,000 (-106.56%)

Capital Expenditure

$104,000 (-63.12%)

$282,000 (244.62%)

-$195,000 (69.81%)

-$646,000 (59.27%)

Issuance (Repayment) of Debt Securities

-$21,563,000 (0%)

$0 (0%)

$142,000 (-99.42%)

$24,519,000 (33687.67%)

Issuance (Purchase) of Equity Shares

$5,223,000 (-90.48%)

$54,855,000 (164.96%)

$20,703,000 (-47.40%)

$39,356,000 (43.06%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$7,419,000 (-20.90%)

$9,379,000 (-18.82%)

$11,553,000 (-16.36%)

$13,813,000 (27.29%)

Depreciation Amortization & Accretion

$1,182,000 (-45.78%)

$2,180,000 (-24.31%)

$2,880,000 (-16.50%)

$3,449,000 (29.52%)

UBX Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-

100.00% (0.00%)

100.00%

-

Profit Margin

-

-25392.80% (-1900.54%)

-1269.30%

-

EBITDA Margin

-

-22961.40% (-1909.40%)

-1142.70%

-

Return on Average Equity (ROAE)

-92.40% (9.06%)

-101.60% (-10.08%)

-92.30% (2.02%)

-94.20% (-45.82%)

Return on Average Assets (ROAA)

-45.50% (10.61%)

-50.90% (-12.11%)

-45.40% (20.91%)

-57.40% (-6.10%)

Return on Sales (ROS)

-

-23885.20% (-1885.63%)

-1202.90%

-

Return on Invested Capital (ROIC)

-41.80% (3.69%)

-43.40% (-14.21%)

-38.00% (33.22%)

-56.90% (28.61%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.71 (-64.75%)

-0.43 (67.66%)

-1.34 (52.75%)

-2.84 (25.95%)

Price to Sales Ratio (P/S)

-

110.23 (547.13%)

17.03

-

Price to Book Ratio (P/B)

0.99 (70.79%)

0.58 (-58.87%)

1.42 (-57.70%)

3.35 (21.90%)

Debt to Equity Ratio (D/E)

1.31 (52.67%)

0.86 (-21.39%)

1.09 (23.48%)

0.89 (250.20%)

Earnings Per Share (EPS)

-2.7 (57.21%)

-6.31 (42.00%)

-10.88 (41.03%)

-18.45 (1.86%)

Sales Per Share (SPS)

0 (0%)

0.03 (-97.08%)

0.86 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.5 (53.17%)

-5.34 (34.08%)

-8.11 (47.78%)

-15.53 (8.47%)

Book Value Per Share (BVPS)

1.92 (-72.70%)

7.04 (-34.02%)

10.67 (-34.50%)

16.29 (-41.11%)

Tangible Assets Book Value Per Share (TABVPS)

4.45 (-66.05%)

13.1 (-41.38%)

22.34 (-27.30%)

30.73 (-11.34%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (50.00%)

-2 (33.33%)

-3 (25.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.24 (-5.28%)

-1.17 (45.45%)

-2.15 (33.23%)

-3.22 (12.54%)

Asset Turnover

0 (0%)

0 (-94.44%)

0.04 (0%)

0 (0%)

Current Ratio

5.95 (20.83%)

4.92 (-9.66%)

5.45 (-21.91%)

6.97 (-7.27%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$36,984,000 (27.12%)

-$50,747,000 (-12.14%)

-$45,255,000 (42.70%)

-$78,979,000 (-6.72%)

Enterprise Value (EV)

$44,772,895 (-29.59%)

$63,590,916 (-45.94%)

$117,632,301 (-59.04%)

$287,183,063 (-1.99%)

Earnings Before Tax (EBT)

-$39,860,000 (33.49%)

-$59,927,000 (1.31%)

-$60,725,000 (35.29%)

-$93,844,000 (-14.20%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$36,226,000 (33.15%)

-$54,189,000 (0.88%)

-$54,668,000 (38.65%)

-$89,103,000 (-12.06%)

Invested Capital

$61,586,000 (-55.81%)

$139,352,000 (9.59%)

$127,161,000 (-30.52%)

$183,025,000 (92.48%)

Working Capital

$38,765,000 (-49.60%)

$76,915,000 (4.10%)

$73,887,000 (-14.49%)

$86,403,000 (-23.04%)

Tangible Asset Value

$65,690,000 (-47.17%)

$124,350,000 (-0.29%)

$124,712,000 (-20.22%)

$156,319,000 (3.37%)

Market Capitalization

$28,217,895 (-27.44%)

$38,886,916 (-53.86%)

$84,277,301 (-69.60%)

$277,265,063 (-16.29%)

Average Equity

$43,159,750 (-26.86%)

$59,008,750 (-10.31%)

$65,794,000 (-33.97%)

$99,642,250 (-21.71%)

Average Assets

$87,555,750 (-25.61%)

$117,701,250 (-11.97%)

$133,712,750 (-18.19%)

$163,443,750 (7.55%)

Invested Capital Average

$89,446,250 (-31.12%)

$129,866,250 (-14.23%)

$151,418,250 (-6.87%)

$162,588,000 (57.61%)

Shares

14,620,671 (3.02%)

14,192,305 (145.86%)

5,772,418 (9.09%)

5,291,318 (15.17%)